These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28295854)

  • 1. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
    Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
    Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion kurtosis imaging for differentiating between the benign and malignant sinonasal lesions.
    Jiang JX; Tang ZH; Zhong YF; Qiang JW
    J Magn Reson Imaging; 2017 May; 45(5):1446-1454. PubMed ID: 27758016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enhanced T
    Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
    Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging and diffusion kurtosis imaging for early evaluation of the response to docetaxel in rat epithelial ovarian cancer.
    Yuan SJ; Qiao TK; Qiang JW
    J Transl Med; 2018 Dec; 16(1):340. PubMed ID: 30518386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
    Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
    Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status.
    Xiao Z; Zhong Y; Tang Z; Qiang J; Qian W; Wang R; Wang J; Wu L; Tang W; Zhang Z
    Eur Radiol; 2018 Jul; 28(7):2923-2933. PubMed ID: 29383521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
    Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
    J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
    Han X; Li B; Sun M; Li J; Li Y; Liu A
    Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of diffusion kurtosis imaging in thyroid nodules and its histopathologic correlation.
    Shi RY; Yao QY; Zhou QY; Lu Q; Suo ST; Chen J; Zheng WJ; Dai YM; Wu LM; Xu JR
    Eur Radiol; 2017 Nov; 27(11):4710-4720. PubMed ID: 28616727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion kurtosis MRI versus conventional diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease.
    Huang L; Li XH; Huang SY; Zhang ZW; Yang XF; Lin JJ; Jiang MJ; Feng ST; Sun CH; Li ZP
    J Magn Reson Imaging; 2018 Mar; 47(3):702-709. PubMed ID: 28577319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel Incoherent Motion Imaging in Differentiation Borderline From Malignant Ovarian Epithelial Tumors: Correlation With Histological Cell Proliferation and Vessel Characteristics.
    Song XL; Wang L; Ren H; Wei R; Ren JL; Niu J
    J Magn Reson Imaging; 2020 Mar; 51(3):928-935. PubMed ID: 31373117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging?
    Wan Q; Deng YS; Lei Q; Bao YY; Wang YZ; Zhou JX; Zou Q; Li XC
    Eur Radiol; 2019 Mar; 29(3):1607-1615. PubMed ID: 30255258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between DKI and DWI with Ki-67 in gastric adenocarcinoma.
    Yuan L; Lin X; Zhao P; Ma H; Duan S; Sun S
    Acta Radiol; 2023 May; 64(5):1792-1798. PubMed ID: 36740857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion kurtosis imaging in sacroiliitis to evaluate the activity of ankylosing spondylitis.
    Wang F; Chu C; Zhao C; Wei Y; Zhang Q; Feng Q; Chen W; He J; Sun L; Zhou Z
    J Magn Reson Imaging; 2019 Jan; 49(1):101-108. PubMed ID: 30102434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
    Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
    Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.